About Dr. Rajeev Vijayakumar

• Dr. Rajeev Vijayakumar is a leading name in the field of Medical Oncology and Hemato-Oncology, with over 20 years of experience.
• His clinical practice covers the full spectrum of solid tumors and hematological malignancies, including breast cancer, lung cancer, gastrointestinal cancers, lymphomas, leukemias, and multiple myeloma.
• He has particular expertise in performing and managing Autologous Stem Cell Transplants (ASCT) and has extensive experience in chemotherapy, immunotherapy, and targeted molecular therapy.
• Dr. Rajeev completed his MBBS from Kempegowda Institute of Medical Sciences (KIMS), Bangalore, in 2005, where he developed an early interest in internal medicine and oncology.
• He went on to complete his DNB in General Medicine from St. Martha’s Hospital, Bangalore, in 2010, where he trained extensively in managing complex medical conditions and systemic diseases.
• His pursuit of excellence led him to the Apex Institute of the Armed Forces, Army Hospital (Research and Referral), New Delhi, one of India’s most prestigious centers, where he obtained his DNB in Medical Oncology (2015) with specialization in Hemato-Oncology and Bone Marrow Transplantation (BMT).
• Dr. Rajeev also holds the MRCP (UK) and the European Society of Medical Oncology (ESMO) Certification in Medical Oncology, reflecting his adherence to global standards in cancer care.
• Before joining Gleneagles Global Hospital, Bangalore, Dr. Rajeev trained and worked under the mentorship of Dr. Rakesh Chopra, one of India’s most respected oncologists.
• He later served as Consultant in Medical Oncology at Narayana Health, Mazumdar Shaw Cancer Center, and subsequently as Associate Consultant at Artemis Hospital, Gurgaon.
• His academic and clinical journey reflects a perfect balance between technical proficiency, empathy, and leadership in patient care.
• In addition to his clinical excellence, Dr. Rajeev has a strong interest in research, medical education, and awareness programs.
• He has presented papers at national and international conferences and published in peer-reviewed oncology journals.
• His areas of academic interest include targeted therapy in solid tumors, immuno-oncology, and transplantation medicine.